Cargando…
Synergistic anti-proliferative and pro-apoptotic activities of 5F and cisplatin in human non-small cell lung cancer NCI-H23 cells
Two-drug combination chemotherapy, often including cisplatin and one other drug, remains the standard of care for patients with advanced non-small cell lung cancer (NSCLC). To improve the treatment of late-stage NSCLC and decrease the toxicity of combination chemotherapy, the search for novel drugs...
Autores principales: | Li, Yuchan, Li, Wende, Deng, Wusheng, Gan, Yuhong, Wu, Kefeng, Sun, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652240/ https://www.ncbi.nlm.nih.gov/pubmed/29098029 http://dx.doi.org/10.3892/ol.2017.6848 |
Ejemplares similares
-
Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells
por: Cervello, Melchiorre, et al.
Publicado: (2013) -
Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells
por: Youssef , Mohieldin M., et al.
Publicado: (2016) -
Metformin synergistically enhances antiproliferative
effects of cisplatin and etoposide in NCI-H460 human lung cancer cells
por: Teixeira, Sarah Fernandes, et al.
Publicado: (2013) -
Combination of ERK2 inhibitor VX-11e and voreloxin synergistically enhances anti-proliferative and pro-apoptotic effects in leukemia cells
por: Jasek-Gajda, Ewa, et al.
Publicado: (2019) -
Anti-proliferative and pro-apoptotic activity of glycosidic derivatives of lawsone in melanoma cancer cell
por: de Franca, Mariana Nobre Farias, et al.
Publicado: (2021)